
CAS Number5002-47-1
SynonymsFluphenazine depot; 1-decanoyloxy-2-{4-[3-(2-trifluoromethyl-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethane; Modecate; Fluphenaline decanoate; Fluphenazindecanoat; Moditen-depo; Fluorophenazine decanoate; Dapotum D; Fluphenazine decanoate; fluphenazine O-decanoate; Flufenazine decanoate; Fluphenazindecanat; Moditen depot
Molecular FormulaC32H44F3N3O2S
Molecular Weight591.77
Purity98.00%
Density1.149 g/cm3
Boiling Point658.1ºCat 760 mmHg
Melting Point30-32°
EINECS225-672-4
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 5002-47-1 |
| Catalog No. | 2A-9031372 |
| Chinese Name | 癸氟奋乃静 |
| Synonyms | Fluphenazine depot; 1-decanoyloxy-2-{4-[3-(2-trifluoromethyl-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethane; Modecate; Fluphenaline decanoate; Fluphenazindecanoat; Moditen-depo; Fluorophenazine decanoate; Dapotum D; Fluphenazine decanoate; fluphenazine O-decanoate; Flufenazine decanoate; Fluphenazindecanat; Moditen depot |
| Molecular Formula | C32H44F3N3O2S |
| Molecular Weight | 591.77 |
| Purity | 98.00 |
| Density | 1.149 g/cm3 |
| Boiling Point | 658.1ºCat 760 mmHg |
| Melting Point | 30-32° |
| Water Solubility | Practically insoluble in water, very soluble in et |
| Storage Condition | 2-8℃ |
| Packaging | II |
| Application | Fluphenazine decanoate is a long-acting phenothiazine antipsychotic used to treat schizophrenia. Fluphenazine decanoate is also a strong and continuous dopamine D2 receptor blocker. |
| EINECS | 225-672-4 |
| HTC | 3003909090 |
| MDL Number | MFCD00798504 |
| SMILES | FC(F)(F)c1cc2c(cc1)Sc3c(cccc3)N2CCCN4CCN(CC4)CCOC(=O)CCCCCCCCC |
| InChI | 1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3 |
| InChI Key | VIQCGTZFEYDQMR-UHFFFAOYSA-N |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| Hazard Symbols | 6.1(a) |
| MSDS | msds/31372_1_5002_47_1.pdf |
| Use of | Fluphenazine decanoate is a long-acting phenothiazine neuroleptic that used to treat schizophrenia. Fluphenazine decanoate is also a high and continuous dopamine D2 receptor blocker[1][2][3]. Properties Articles26 Name 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate Synonym More Synonyms Fluphenazine decanoate Biological Activity Description Fluphenazine decanoate is a long-acting phenothiazine neuroleptic that used to treat schizophrenia. Fluphenazine decanoate is also a high and continuous dopamine D2 receptor blocker[1][2][3]. Related Catalog Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor Research Areas >> Neurological Disease Dopamine D2 receptor[2] References [1]. Wagman JD, et al. The effect of fluphenazine decanoate on glucocorticoid production, reproductive cyclicity, and the behavioral stress response in the Persian onager (Equus hemionus onager). Zoo Biol. 2015 Nov;34(6):525-34. [2]. Uchida H, et al. Dose and dosing frequency of long-acting injectable antipsychotics: a systematic review of PET and SPECT data and clinical implications. J Clin Psychopharmacol. 2014 Dec;34(6):728-35. [3]. Weiss RB, et al. Long-acting neuroleptic use for reproductive management of non-domestic ungulates using the domestic goat (Capra hircus) as a model. Zoo Biol. 2014 May-Jun;33(3):204-11. Chemical & Physical Properties Molecular Formula C32H44F3N3O2S Exact Mass 591.31100 PSA 61.32000 LogP 7.94050 Index of Refraction 1.537 InChIKey VIQCGTZFEYDQMR-UHFFFAOYSA-N Storage condition 2-8℃ Water Solubility Practically insoluble in water, very soluble in ethanol and in methylene chloride, freely soluble in methanol. Toxicological Information CHEMICAL IDENTIFICATION RTECS NUMBER : CHEMICAL NAME : Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl )- 1-piperazinyl)ethyl ester CAS REGISTRY NUMBER : LAST UPDATED : DATA ITEMS CITED : MOLECULAR FORMULA : C32-H44-F3-N3-O2-S MOLECULAR WEIGHT : WISWESSER LINE NOTATION : T C666 BN ISJ EXFFF B3- AT6N DNTJ D2OV9 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Human - man DOSE/DURATION : TOXIC EFFECTS : Behavioral - muscle contraction or spasticity TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : DOSE/DURATION : TOXIC EFFECTS : Behavioral - antipsychotic TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Human - woman DOSE/DURATION : TOXIC EFFECTS : TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Human - man DOSE/DURATION : 1071 ug/kg/12D-I TOXIC EFFECTS : Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea Skin and Appendages - sweating TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - effect, not otherwise specified Lungs, Thorax, or Respiration - respiratory depression Nutritional and Gross Metabolic - body temperature decrease TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - altered sleep time (including change in righting reflex) Skin and Appendages - hair TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Sense Organs and Special Senses (Eye) - effect, not otherwise specified Behavioral - altered sleep time (including change in righting reflex) Skin and Appendages - hair TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Liver - changes in liver weight Kidney, Ureter, Bladder - other changes in urine composition Nutritional and Gross Metabolic - weight loss or decreased weight gain TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Mammal - dog DOSE/DURATION : TOXIC EFFECTS : Blood - normocytic anemia Blood - changes in bone marrow (not otherwise specified) Related to Chronic Data - changes in prostate weight TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SEX/DURATION : male 4 week(s) pre-mating female 2 week(s) pre-mating female 1-7 day(s) after conception TOXIC EFFECTS : Reproductive - Maternal Effects - menstrual cycle changes or disorders TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SEX/DURATION : female 17 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Newborn - stillbirth Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive) Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SEX/DURATION : female 17 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) Reproductive - Effects on Newborn - delayed effects TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intramuscular SEX/DURATION : female 7 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Newborn - sex ratio MUTATION DATA TEST SYSTEM : Rodent - rat DOSE/DURATION : REFERENCE : MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 244,331,1990 *** REVIEWS *** TOXICOLOGY REVIEW ABPYBL Advances in Biochemical Psychopharmacology. (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) V.1- 1969- Volume(issue)/page/year: 9,301,1974 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5576 No. of Facilities: 16 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 794 (estimated) No. of Female Employees: 419 (estimated) Safety Information Hazard Codes Xn RIDADR UN 3249 RTECS HE0525000 Packaging Group II Hazard Class 6.1(a) HS Code 3003909090 |
| Transport Info | Product Name: Decylphenazine |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Fludiazepam | 3900-31-0 | 2A-9030277 |
| Sotalol | 3930-20-9 | 2A-9030302 |
| Erythromycin phosphate | 4501-00-2 | 2A-9030971 |
| Bekanamycin | 4696-76-8 | 2A-9031121 |
| 17-Ethynylestriol | 4717-40-2 | 2A-9031139 |
| Beclomethasone dipropionate | 5534-09-8 | 2A-9031952 |
| Clozapine | 5786-21-0 | 2A-9032171 |
| Theophylline monohydrate | 5967-84-0 | 2A-9032358 |
| Olsalazine disodium | 6054-98-4 | 2A-9032442 |
| Procaine penicilline G hydrate | 6130-64-9 | 2A-9032498 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA